ReviewBiological trace element research2026
Systematic Review and Meta-Analysis on the Association Between Cadmium and Mercury, with Polycystic Ovary Syndrome.
Review in Biological trace element research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder with multifactorial etiology. Cadmium (Cd) and mercury (Hg) are potent endocrine-disrupting metals, yet their association with PCOS remains inconsistent. These metals were targeted due to their high prevalence, established ovarian toxicity, and shared mechanistic pathways relevant to PCOS. Following PRISMA guidelines, we searched PubMed, Scopus, Web of Science, and Embase through December 2025 for observational studies comparing Cd/Hg concentrations between women with PCOS and controls. Quality was assessed via the Newcastle-Ottawa Scale; pooled standardized mean differences (SMDs) were calculated using random-effects models. Eleven studies (1,960 cases; 2,696 controls) were included. Women with PCOS exhibited significantly higher cadmium (SMD = 0.42, 95% CI: 0.09-0.75; I²=95.6%) and mercury (SMD = 0.57, 95% CI: 0.23-0.91; I²=95.8%) concentrations than controls. Egger's test indicated potential publication bias; trim-and-fill adjustment yielded corrected SMDs of 0.78 (95% CI: 0.34-1.22) for cadmium and 0.76 (95% CI: 0.41-1.11) for mercury, indicating slight underestimation of true effects. Meta-regression for mercury identified biological matrix (p = 0.002) and geographical location (p = 0.026) as significant moderators; bubble plots confirmed attenuation of the Hg-PCOS association when shifting from serum to whole blood or urine. No significant predictors explained cadmium's heterogeneity, suggesting unmeasured individual factors. This meta-analysis provides quantitative evidence linking Cd and Hg exposure to PCOS. The choice of biological matrix is a critical determinant in assessing mercury's impact. These findings advocate for standardized environmental exposure assessments and longitudinal studies to establish causality and inform preventive public health strategies.
Indexed as
Identifiers
42762426What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.